Corporate In-expo, Innovation Hub Session: Embrace Your First Case: Insights and Guidance for Getting Started with Embrace™ Hydrogel Embolic System (Presented by Instylla)

Interventional radiologists Edgar St. Amour, MD and Ripal Gandhi, MD share insights from their early clinical experience with the Embrace™ Hydrogel Embolic System, the first and only FDA-approved liquid embolic indicated for hypervascular tumor embolization.

Dr. St. Amour is the lead enroller in the prospective, randomized, multi-center pivotal trial and will share perspectives from his early experience using the system, including patient selection with hypervascular tumors. Dr. Gandhi performed the first commercial procedure in the US and will review his experience discussing considerations made while selecting his first patient for Embrace HES, key procedural details, and his takeaways on the differentiating aspects of the product.

Through an interview-style discussion, the faculty will share tips on technique, setup and workflow, and other practical considerations to help physicians get started with their first case. Audience participation and questions are encouraged.